Burning Rock Biotech Limited American Depositary Shares (BNR)
Burning Rock Biotech Limited American Depositary Shares (BNR) is listed on Nasdaq, where it has traded since June 12, 2020.
- Listed On
- Nasdaq
- Listed Since
- June 12, 2020
- Employees
- 667
- Market Cap
- $196M
About Burning Rock Biotech Limited American Depositary Shares
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 17 institutions reported holding BNR, with 1.7 million shares worth $14.7 million in aggregate. The largest reported holder was Kynam Capital Management, with 1.2 million shares worth $10.5 million. Of the 5 largest holders listed below, 3 added shares and 2 reduced their positions during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Kynam Capital Management | 1,238,563 | $11M | Added 0.9% |
| Crcm | 211,997 | $2M | Reduced 24.85% |
| Renaissance Technologies | 52,838 | $442K | Added 49.23% |
| Morgan Stanley | 43,594 | $365K | Added 185.45% |
| Amova Asset Management Americas | 29,724 | $258K | Reduced 1.37% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is BNR?
Burning Rock Biotech Limited American Depositary Shares (BNR) is listed on Nasdaq, where it has traded since June 12, 2020.
Who are the largest institutional holders of BNR?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of BNR were Kynam Capital Management, Crcm and Renaissance Technologies.
How many institutions own BNR?
17 institutions reported a position in BNR for the quarter ended June 30, 2026, worth $14.7 million in total.
Did institutions buy or sell BNR last quarter?
Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter. Every reported holder and its change is on the SentiSense ownership page for BNR.
Every reported institutional holder, plus insider and congressional trades in BNR, on SentiSense.